TIGRIS意大利多中心注册研究:双组件支架股腘动脉补救性支架置入后通畅性丧失的预后危险因素
前瞻性多中心单臂注册研究纳入156例股腘动脉病变患者,采用Gore Tigris肝素涂层镍钛合金支架行补救性支架置入,1、6、12个月原发通畅率分别为99%、86%、81%,Rutherford评分≥4分和既往严重治疗是早期通畅性丧失的危险因素,腘动脉受累并非独立危险因素。
要点
- 补救性支架置入后1、6、12个月原发通畅率分别为99%、86%、81%。
- Rutherford评分≥4分和既往同部位严重治疗是早期通畅性丧失的危险因素。
- 腘动脉受累并非通畅性丧失的独立危险因素。
核心结论
- 第三代镍钛合金支架补救性支架置入治疗股腘动脉回缩、夹层或残余狭窄对经皮腔内血管成形术(PTA)无反应者是安全有效的选择;严重肢体缺血和既往同部位重大治疗史是随访期间通畅性丧失的显著预后因素。
研究设计与样本
- 前瞻性、多中心、单臂注册研究,纳入9个中心156例患者(50例女性,平均年龄72±11岁),2017年2月至2018年12月期间对194处Rutherford评分≥3的病变行Gore Tigris血管支架补救性支架置入,随访采用临床评估和 duplex 超声(DUS)在1、6、12个月进行。
诊断标准与关键数值
- 原发通畅率1个月为99%(95%CI 98-100%),6个月为86%(95%CI 80-92%),12个月为81%(95%CI 74-88%);通畅性丧失后23例中13例(56.5%)接受再治疗,一期辅助通畅率6个月为91%(95%CI 86-96%)、12个月为88%(95%CI 82-94%),二期通畅率6个月为94%(95%CI 90-98%)、12个月为90%(95%CI 84-95%)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify the risk factors associated with patency loss after bailout stenting with third-generation hybrid heparin-bonded nitinol stent of the femoropopliteal segment.
METHODS: Prospective, multicenter, single-arm registry including 156 patients (50 females, mean age 72 ± 11 years) subjected, from February 2017 to December 2018, to provisional stenting with Gore Tigris vascular stent of the distal superficial femoral artery, with or without involvement of the popliteal artery, in 9 different centers. The 194 lesions, with Rutherford score ≥ 3, were stented in case of recoil, dissection or residual stenosis not responding to percutaneous trans-luminal angioplasty (PTA). The follow-up (FU) was performed with clinical evaluation and duplex ultrasound (DUS) at 1, 6 and 12 months.
RESULTS: The primary patency rate was 99(95%CI 98-100)% at 1 month, 86(80-92)% at 6 months and 81(74-88)% at-12 months. After patency loss, 13/23 (56.5%) patients were re-treated, yielding a primary assisted patency of 91(86-96)% at 6 months and 88(82-94)% at 12 months and a secondary patency of 94(90-98)% at 6 months and 90(84-95)% at 12 months. Rutherford score ≥ 4 (p = 0.03) and previous severe treatments (p = 0.01) were identified as risk factors for early patency loss during FU. The involvement of the popliteal artery was not an independent risk factor for loss of patency.
CONCLUSIONS: The bailout stenting of the femoropopliteal segment with third-generation nitinol stents is a safe and effective option in case of recoil, dissection or residual stenosis not responding to PTA. Critical limb ischemia and history of previous major treatment at the same level are significant prognostic factors for patency loss during FU.
引用
- Ruffino MA, Fronda M, Bergamasco L, et al. Prognostic risk factors for loss of patency after femoropopliteal bailout stenting with dual-component stent: results from the TIGRIS Italian Multicenter Registry. Radiol Med. 2021. PMID: 34057667. doi:10.1007/s11547-021-01373-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。